NDC 0573-2620-06 - ALAVERT ALLERGY
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0573-2620
- Requested NDC
- 0573-2620-06
- Package NDCs from labels
- 0573-2620-19, 0573-2620-01, 0573-2620-65, 0573-2620-71, 0573-2620-06
- Manufacturer
- Haleon US Holdings LLC
- Effective date
- 2024-03-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ALAVERT ALLERGY - Haleon US Holdings LLC | Haleon US Holdings LLC | 2024-03-21 | HUMAN OTC DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-11 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 0573-2620-01 | 2024-03-21 | Drug Facts |
| 0573-2620-19 | 2024-03-21 | Drug Facts |
| 0573-2620-65 | 2024-03-21 | Drug Facts |
| 0573-2620-71 | 2024-03-21 | Drug Facts |
| 0573-2620-01 | 2022-01-28 | Drug Facts |
| 0573-2620-19 | 2022-01-28 | Drug Facts |
| 0573-2620-65 | 2022-01-28 | Drug Facts |
| 0573-2620-71 | 2022-01-28 | Drug Facts |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0573-2620-06 | EA - Each | 0573-2620 | a426c267-75e5-4ee7-9ccb-d16f65916fb8 | 1 | 2013-02-11 |
| 0573-2620-19 | EA - Each | 0573-2620 | 803dfd04-b25f-4194-9168-06ac17863609 | 1 | 2012-07-24 |
| 0573-2620-30 | EA - Each | 0573-2620 | 7da8de28-0e7a-453a-81e4-006ec98783a2 | 1 | 2014-01-04 |
| 0573-2620-65 | EA - Each | 0573-2620 | 526cf195-dcb5-4dc1-ab35-715787f1e3d7 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loratadine | LORATADINE | WALGREEN COMPANY | 3881afaf-8d0d-4154-85a8-79a3c7806b49 | 2026-10-27 | Warnings | 7AJO3BO7QN |
| Loratadine Allergy Relief | LORATADINE | Marlex Pharmaceuticals, Inc. | ec08a6ee-3d71-0fa9-e053-2995a90a9cb1 | 2026-10-27 | Warnings | 7AJO3BO7QN |
| Zegerid OTC | OMEPRAOLE, SODIUM BICARBONATE | Riley Consumer Care LLC | 8d00c19a-d86b-4a2f-8791-b320ad3ca781 | 2026-10-26 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate 10 gr | SODIUM BICARBONATE | GRAXCELL PHARMACEUTICAL, LLC | 897dbb09-fb47-4e03-8cae-bf76d48a7a03 | 2026-10-26 | Warnings | 8MDF5V39QO |
| Loratadine | LORATADINE | A-S Medication Solutions | 64737ead-8fb4-43c8-8a09-9cfd5c8f702b | 2026-10-26 | Warnings | 7AJO3BO7QN |
| childrens allergy relief | LORATADINE | Amazon.com Services LLC | fefd15c9-e55a-4058-b71d-232acb1084cf | 2026-10-19 | Warnings | 7AJO3BO7QN |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Rugby Laboratories | e73b5871-4a87-4473-ab00-5e5395be017d | 2026-10-16 | Warnings | 8MDF5V39QO |
| After Bite Advanced | SODIUM BICARBONATE | Tender Corporation d/b/a Adventure Ready Brands | 223d1de8-7940-bbdc-e063-6294a90a51d8 | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 1484a825-40c6-a9c9-e063-6294a90a9ca4 | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-300 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | c3cd7f0f-8d70-23af-e053-2a95a90a569b | 2026-10-16 | Warnings | 8MDF5V39QO |
| QUABIC-100 | HEMODIALYSIS GRADE SODIUM BICARBONATE SOLUTION | Aqua Medica, S.A. de C.V. | 28152c9f-b15c-3707-e063-6394a90a70e9 | 2026-10-16 | Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Sun Pharmaceutical Industries, Inc. | 5ae65432-04a1-4b6b-8536-2535064fc782 | 2026-10-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| Good Sense Omeprazole and Sodium Bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | L. Perrigo Company | bcf32242-de17-4da1-b707-4ce26262eb78 | 2026-10-14 | Warnings | 8MDF5V39QO |
| Loratadine and Pseudoephedrine | LORATADINE AND PSEUDOEPHEDRINE | Ohm Laboratories Inc. | bbe83464-a582-469f-8fac-f98e804d96fe | 2026-10-12 | Warnings | 7AJO3BO7QN |
| Sal De Uvas Picot | CITRIC ACID MONOHYDRATE, SODIUM BICARBONATE | Navajo Manufacturing Company Inc. | ff6ac79d-564d-4abf-83c7-b01751249c7f | 2026-10-09 | Warnings | 8MDF5V39QO |
| Loratadine | LORATADINE | Granules Pharmaceuticals Inc. | d15add22-bc2d-9730-e053-2a95a90acd3f | 2026-10-08 | Warnings | 7AJO3BO7QN |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 8MDF5V39QO |
| Loratadine | LORATADINE | Granules India Limited | 9bae1ba3-c0da-23a2-e053-2a95a90a58ed | 2026-10-07 | Warnings | 7AJO3BO7QN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.